Using the Electronic Common Technical Document in Regulatory Filings
This article was originally published in SRA
Hans van Bruggen looks at progress with the introduction of eCTD in Europe, the EU and Japan and identifies the benefits and shortcomings in its current use.
You may also be interested in...
Despite seeing an 8% drop in global turnover in 2019, an upbeat Teva says the completion of its restructuring plan has positioned the company to increase its turnover through newly-launched products – including biosimilars, brands and new generics – as well as improve its profit margins through manufacturing optimization.
Japanese big pharma Eisai taps Celgene and Sanofi execs as its new VPs for corporate affairs and market access. And Freeline Therapeutics, developer of gene therapies for bleeding disorders, selects a former Alnylam Pharma SVP as CEO.